| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.014 | 0.8 |